+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma



Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma



Gynecologic Oncology 114(3): 390-394



Chlamydia trachomatis (Ct) has been implicated as a co-factor in cervical carcinogenesis. The goal of the current study was to investigate if Ct may play a role in pathogenesis of cervical adenocarcinoma and, specifically, if there is a co-infection between Ct and Human Papillomavirus (HPV) in cervical adenocarcinomas. The second goal of the study was to determine the distribution of HPV genotypes in most recent cases of in-situ and invasive cervical adenocarcinomas. Biopsies of 71 cervical adenocarcinomas (31 in-situ and 40 invasive) were tested for the presence of Ct using two novel PCR assays. In addition, all cases were tested for HPV using SPF10-PCR assay and genotyped using LIPA(25) test. None of the cases was found to be positive for Ct using two independent PCR assays. All lesions, however, were positive for HPV with the exception of a case of minimal deviation adenocarcinoma. Overall, 94.2% of cases were positive for either HPV16 (n=44, 62.8%) or HPV18 (n=20, 28.5%), or both (n=2, 2.8%). Other single HPV types included HPV45 (n=3, 4.2%) and HPV35 (n=1, 1.4%). The study demonstrated lack of co-infection between Human Papillomavirus and C. trachomatis in in-situ and invasive adenocarcinoma of the uterine cervix. The role of Ct as a carcinogenetic co-factor may be restricted to cervical squamous cell carcinomas. Accounting for type cross-protection, currently available HPV vaccines are likely to prevent close to 100% of HPV-positive cervical adenocarcinomas.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269696

Download citation: RISBibTeXText

PMID: 19500822

DOI: 10.1016/j.ygyno.2009.05.013


Related references

Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. Journal of Infectious Diseases 185(3): 324-331, 2002

Low prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma in situ, invasive adenocarcinoma, and glandular dysplasia by polymerase chain reaction. Modern Pathology 6(4): 433-437, 1993

Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women. International Journal of Gynecological Cancer 21(8): 1486-1490, 2012

Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma. A study by in situ hybridization with biotinylated DNA probes. Cancer 65(11): 2588-2593, 1990

Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization. International Journal of Gynecological Pathology 10(1): 36-43, 1991

The human papillomavirus status of invasive cervical adenocarcinoma: A clinicopathological and outcome analysis. Human Pathology 26(3): 319-325, 1995

Chlamydia trachomatis, human papillomavirus, bacterial vaginosis and cervical neoplasia. Archives of Gynecology and Obstetrics 289(6): 1155-1155, 2014

Human papillomavirus, Chlamydia trachomatis, and other risk factors associated with cervical cancer in China. International Journal of Clinical Oncology 3(2): 81-87, April, 1998

Chlamydia trachomatis and Human papillomavirus infections in cervical disease in Argentine women. Gynecologic Oncology 96(1): 181-186, 2004

Comparison of the Masaoka-Koga Classification with the New TNM Staging of the IASLC/ITMIG for Thymoma and Thymic Carcinoma. Zentralblatt für Chirurgie, 2018

Detection of Chlamydia trachomatis DNA in cervical samples with regard to infection by human papillomavirus. Journal of Infection 38(1): 12-17, 1999

Role of current infection with Chlamydia trachomatis and human papillomavirus in the development of cervical cancer. International Journal of STD & AIDS 12(Supplement 2): 40, 2001

Chlamydia trachomatis infection and human papillomavirus in women with cervical neoplasia in Pernambuco-Brazil. Molecular Biology Reports 41(2): 865-874, 2014

Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas. Pathology International 56(6): 301-308, 2006